European Journal of Surgical Oncology
Volume 33, Issue 4 , Pages 435-437, May 2007

Prediction in breast cancer of the extent of axillary node involvement from the size and lymphovascular invasion status of the primary tumour: Medico-legal considerations

Department of Surgery, Breast Care Unit, Victoria Hospital NHS Trust, Whinney Heys Road, Blackpool, Lancashire, FY3 8NR, UK

Accepted 20 October 2006.

Abstract 

Aim

To ascertain for medico-legal purposes in the United Kingdom, the extent to which in breast cancer primary tumour size and lympho-vascular invasion (LVI) status determine axillary node staging.

Methods

Four hundred and fifty symptomatic patients had their tumour sizes stratified into 1cm ranges and the percentage incidence/probability of the axillary stage being 1, 2 or 3 was calculated separately for those tumours that showed no evidence of LVI and those that did.

Results

The presence of LVI has a marked effect on the likelihood and extent of axillary node involvement for all primary tumour sizes.

Conclusions

This needs to be recognized and quantified when prediction of this extent is made for medico-legal purposes. Within the constraints of the ‘balance of probabilities’ argument in UK law, it is rarely possible to differentiate between the likelihood of the axillary stage being 2 or 3.

Keywords: Breast cancer, Tumour size, Axillary node status, Lympho-vascular invasion, Medico-legal aspects

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(06)00425-2

doi:10.1016/j.ejso.2006.10.031

European Journal of Surgical Oncology
Volume 33, Issue 4 , Pages 435-437, May 2007